South Korea · Delayed Price · Currency is KRW Genesem Statistics
Total Valuation
Genesem has a market cap or net worth of KRW 77.61 billion. The enterprise value is 86.87 billion.
| Market Cap | 77.61B |
| Enterprise Value | 86.87B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Genesem has 13.15 million shares outstanding. The number of shares has decreased by -0.10% in one year.
| Current Share Class | 13.15M |
| Shares Outstanding | 13.15M |
| Shares Change (YoY) | -0.10% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 44.53% |
| Owned by Institutions (%) | n/a |
| Float | 7.30M |
Valuation Ratios
The trailing PE ratio is 159.66.
| PE Ratio | 159.66 |
| Forward PE | n/a |
| PS Ratio | 1.41 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 1.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 103.51, with an EV/FCF ratio of -12.04.
| EV / Earnings | 178.72 |
| EV / Sales | 1.58 |
| EV / EBITDA | 103.51 |
| EV / EBIT | n/a |
| EV / FCF | -12.04 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.37.
| Current Ratio | 1.39 |
| Quick Ratio | 0.51 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 16.52 |
| Debt / FCF | -2.47 |
| Interest Coverage | -0.20 |
Financial Efficiency
Return on equity (ROE) is 1.09% and return on invested capital (ROIC) is -0.23%.
| Return on Equity (ROE) | 1.09% |
| Return on Assets (ROA) | -0.09% |
| Return on Invested Capital (ROIC) | -0.23% |
| Return on Capital Employed (ROCE) | -0.24% |
| Weighted Average Cost of Capital (WACC) | 10.48% |
| Revenue Per Employee | 350.67M |
| Profits Per Employee | 3.10M |
| Employee Count | 157 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 1.69 |
Taxes
| Income Tax | -698.34M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.11% in the last 52 weeks. The beta is 1.45, so Genesem's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | +31.11% |
| 50-Day Moving Average | 6,633.00 |
| 200-Day Moving Average | 5,805.73 |
| Relative Strength Index (RSI) | 36.66 |
| Average Volume (20 Days) | 311,287 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genesem had revenue of KRW 55.06 billion and earned 486.07 million in profits. Earnings per share was 36.95.
| Revenue | 55.06B |
| Gross Profit | 19.75B |
| Operating Income | -126.68M |
| Pretax Income | -173.12M |
| Net Income | 486.07M |
| EBITDA | 1.08B |
| EBIT | -126.68M |
| Earnings Per Share (EPS) | 36.95 |
Balance Sheet
The company has 8.42 billion in cash and 17.80 billion in debt, with a net cash position of -9.38 billion or -712.77 per share.
| Cash & Cash Equivalents | 8.42B |
| Total Debt | 17.80B |
| Net Cash | -9.38B |
| Net Cash Per Share | -712.77 |
| Equity (Book Value) | 48.01B |
| Book Value Per Share | 3,644.11 |
| Working Capital | 13.02B |
Cash Flow
In the last 12 months, operating cash flow was -5.06 billion and capital expenditures -2.15 billion, giving a free cash flow of -7.21 billion.
| Operating Cash Flow | -5.06B |
| Capital Expenditures | -2.15B |
| Depreciation & Amortization | 1.20B |
| Net Borrowing | -2.54B |
| Free Cash Flow | -7.21B |
| FCF Per Share | -548.31 |
Margins
Gross margin is 35.88%, with operating and profit margins of -0.23% and 0.88%.
| Gross Margin | 35.88% |
| Operating Margin | -0.23% |
| Pretax Margin | -0.31% |
| Profit Margin | 0.88% |
| EBITDA Margin | 1.96% |
| EBIT Margin | -0.23% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.85%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 0.85% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 270.61% |
| Buyback Yield | 0.10% |
| Shareholder Yield | 0.95% |
| Earnings Yield | 0.63% |
| FCF Yield | -9.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 24, 2025. It was a forward split with a ratio of 1.5.
| Last Split Date | Nov 24, 2025 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Genesem has an Altman Z-Score of 2.18 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.18 |
| Piotroski F-Score | 3 |